Institutional Ownership
Amgen Inc
CUSIP 031162100COMAMGNQ1 2026
Latest EPS (Diluted)
$3.34
Q1 2026 · Mar 31, 2026
Latest Revenue
$8.62B
Reported quarter
Latest Net Income
$1.82B
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $3.37 | $3.34 | $8.62B | $1.82B | 10-Q |
| Sep 30, 2025 | Q3 2025 | $5.98 | $5.93 | $9.56B | $3.22B | 10-Q |
| Jun 30, 2025 | Q2 2025 | $2.66 | $2.65 | $9.18B | $1.43B | 10-Q |
| Mar 31, 2025 | Q1 2025 | $3.22 | $3.20 | $8.15B | $1.73B | 10-Q |
| Sep 30, 2024 | Q3 2024 | $5.27 | $5.22 | $8.50B | $2.83B | 10-Q |
| Jun 30, 2024 | Q2 2024 | $1.39 | $1.38 | $8.39B | $746.00M | 10-Q |
| Mar 31, 2024 | Q1 2024 | $-0.21 | $-0.21 | $7.45B | -$113.00M | 10-Q |
| Sep 30, 2023 | Q3 2023 | $3.23 | $3.22 | $6.90B | $1.73B | 10-Q |
| Jun 30, 2023 | Q2 2023 | $2.58 | $2.57 | $6.99B | $1.38B | 10-Q |
| Mar 31, 2023 | Q1 2023 | $5.32 | $5.28 | $6.11B | $2.84B | 10-Q |
| Sep 30, 2022 | Q3 2022 | $4.01 | $3.98 | $6.65B | $2.14B | 10-Q |
| Jun 30, 2022 | Q2 2022 | $2.46 | $2.45 | $6.59B | $1.32B | 10-Q |